Eliquis

AstraZeneca Plc explored an acquisition of Bristol Myers Squibb Co., which could create one of the world's largest drugmakers. Bristol Myers Squibb, with a $133 billion market capitalization, faces patent losses for key drugs like Eliquis and Opdivo, while AstraZeneca has a market value of about £196 billion. Bristol recently reported record quarterly sales of $13 billion driven by newer treatments.

Bristol Myers Squibb is raising its full-year outlook after blood thinner sales exceeded expectations. Strong sales of Eliquis, Camzyos, and Reblozyl pushed second-quarter revenue to $12.97 billion, surpassing analyst estimates.

Medicare Part D, which provides prescription drug coverage, has a 2026 average monthly premium of $34.50, a maximum annual deductible of $615, and an out-of-pocket cap of $2,100. The Inflation Reduction Act of 2022 limits insulin copays to $35 per month, and Part D covers 10 specific drugs with reduced costs. Coverage is structured through tiered pricing and stages, including deductible, initial coverage, and catastrophic phases.

Colorado has received FDA approval to import lower-cost prescription drugs from Canada, aiming to save residents 20-60% on medications like Ozempic and Eliquis. The state is the second in the U.S. to secure such approval, following Florida, and plans to establish a distribution chain within a year.

Colorado has received FDA approval to import lower-cost prescription drugs from Canada, a process initiated by legislation signed in 2019. The state plans to import 20 specific medications, including Ozempic and Eliquis, aiming for savings of up to 60% and $46 million in total over three years.